variou
aminonarylmethanethio
urea
design
keep
view
structur
requir
suggest
pharmacophor
model
anticonvuls
activ
vivo
anticonvuls
screen
perform
two
adopt
seizur
model
maxim
electroshock
seizur
me
subcutan
pentylenetetrazol
scptz
compound
found
activ
me
screen
compound
show
signific
anticonvuls
activ
screen
devoid
neurotox
compound
show
mark
protect
mgkg
me
scptz
screen
compound
also
show
protect
me
screen
dose
mgkg
hz
screen
two
compound
show
signific
protect
emerg
lead
compound
futur
investig
epilepsi
collect
term
given
group
syndrom
involv
spontan
intermitt
abnorm
electr
activ
brain
manifest
seizur
estim
patient
epilepsi
use
first
gener
antiepilept
drug
phenobarbit
phenytoin
carbamazepin
sodium
valproat
diazepam
abl
acquir
adequ
control
seizur
fact
epilepsi
third
frequent
neurolog
disord
encount
elderli
cerebrovascular
diseas
dementia
continu
demand
new
anticonvuls
agent
sever
current
avail
antiepilept
drug
a
associ
sever
side
effect
fail
control
seizur
epilept
patient
search
antiepilept
agent
select
lower
toxic
continu
area
investig
medicin
chemistri
studi
reveal
isatin
privileg
lead
molecul
design
potenti
bioactiv
agent
deriv
shown
possess
broad
spectrum
bioactiv
mani
assess
antihiv
antivir
antitumor
antifung
antiangiogen
anticonvuls
antiparkinson
diseas
therapeut
effect
sar
coronaviru
proteas
inhibitor
interest
properti
prompt
mani
effort
toward
synthesi
pharmacolog
screen
isatin
deriv
consid
extens
applic
isatin
moieti
medicin
chemistri
continu
ongo
project
biolog
activ
heterocycl
attempt
made
synthes
aminonarylmethanethio
urea
deriv
contain
isatin
moieti
evalu
vivo
screen
synthesi
titl
compound
carri
present
scheme
prepar
reflux
mixtur
sulfur
acid
nitric
acid
water
bath
c
h
compound
b
synthes
stir
mixtur
compound
anhydr
potassium
carbon
aceton
substitut
benzyl
chlorid
compound
b
get
reduc
b
heat
mixtur
iron
powder
hydrochlor
acid
compound
b
stir
sodium
cyanat
glacial
acet
acid
get
convert
urea
deriv
b
final
titl
compound
aminonarylmethanethio
urea
prepar
reflux
differ
substitut
phenylisothiocyan
compound
b
physicochem
paramet
synthes
compound
present
tabl
structur
puriti
final
compound
confirm
basi
spectral
element
analys
data
within
theoret
valu
pharmacolog
test
final
compound
perform
nation
institut
neurolog
disord
stroke
nind
usa
anticonvuls
screen
program
asp
follow
protocol
adopt
antiepilept
drug
develop
add
program
compound
prepar
herein
screen
potenti
vivo
biolog
activ
anticonvuls
minim
motor
impair
test
phase
pharmacolog
screen
compris
me
scptz
neurotox
select
compound
test
activ
hz
model
phase
studi
investig
compound
involv
three
test
maxim
electroshock
seizur
me
subcutan
pentylenetetrazol
scptz
rotorod
test
neurolog
toxic
me
assay
experiment
compound
administ
set
one
three
one
anim
three
respect
dose
mgkg
h
h
time
period
similar
standard
dose
time
use
scptz
test
anim
observ
potenti
neurolog
deficit
dose
time
period
identif
anticonvuls
activ
mice
test
compound
administ
intraperiton
challeng
maxim
electroshock
subcutan
pentylenetetrazol
compound
found
effect
seizur
challeng
gener
regard
potenti
use
candid
treatment
partial
gener
even
absenc
seizur
neurotox
test
compound
determin
use
rotorod
toxic
test
tox
result
vivo
test
summar
tabl
titl
compound
aminonarylmethanethio
urea
show
protect
me
scptz
seizur
mice
phase
screen
potent
anticonvuls
compound
found
interestingli
compound
devoid
neurotox
me
test
compound
activ
dose
mgkg
anim
protect
h
administr
interestingli
compound
also
activ
dose
mgkg
anim
protect
h
h
mgkg
dose
compound
also
found
activ
anim
protect
h
anim
protect
h
administr
mgkg
dose
compound
activ
anim
protect
h
administr
scptz
screen
compound
activ
dose
mgkg
anim
protect
h
administr
compound
also
show
protect
dose
mgkg
anim
protect
h
administr
neurotox
screen
compound
found
potent
devoid
minim
motor
impair
dose
rest
compound
although
potent
show
lack
neurotox
compound
display
mark
me
well
scptz
activ
mice
dose
mgkg
ip
evalu
hz
assay
mice
test
result
tabl
result
suggest
thioamid
amid
two
hydrogen
bond
domain
hbd
nitrogen
isatin
electron
donar
unsubstitut
substitut
electron
withdraw
agent
hydrophob
domain
unsubstitut
methoxi
methyl
substitut
electron
donat
agent
distal
hydrophob
domain
r
made
compound
potent
me
screen
mgkg
dose
scptz
screen
mgkg
ip
dose
mice
well
minim
clonic
seizur
hz
test
mgkg
ip
dose
mice
anticonvuls
agent
requir
pharmacophor
element
shown
fig
depend
biolog
activ
set
congener
agent
lipophil
charact
shown
mani
type
drug
action
particular
report
lien
cowork
indic
anticonvuls
activ
differ
type
compound
correl
lipophil
howev
observ
maximum
potenc
drug
act
central
nervou
system
cn
obtain
congen
optimum
lipophil
log
po
studi
attempt
correl
anticonvuls
activ
synthes
compound
log
p
valu
experiment
log
p
valu
determin
use
octanolphosph
buffer
method
calcul
log
p
valu
taken
softwar
chemoffic
result
shown
tabl
synthes
compound
met
criteria
lipophilicti
show
good
anticonvuls
activ
lesser
neurotox
due
higher
lipophil
expect
rapid
onset
shorter
durat
action
pharmacophor
model
anticonvuls
aminonarylmethanethio
urea
establish
basi
result
pharmacolog
physicochem
distanc
map
threedimension
structur
investig
model
presenc
thioamid
amid
hbd
fragment
essenti
activ
besid
compound
contain
two
hydrophob
unit
r
aryl
ring
distal
bind
site
isatin
electron
donar
five
compound
show
better
anticonvuls
activ
among
compound
emerg
lead
compound
seri
subject
preliminari
anticonvuls
screen
also
show
mark
lower
neurotox
therefor
higher
protect
index
regard
strong
candid
futur
investig
chemic
use
obtain
variou
chemic
unit
e
merck
india
ltd
cdh
sd
fine
chem
qualigen
solvent
reagent
lr
grade
purifi
use
silica
gel
g
mesh
use
analyt
chromatographi
tlc
obtain
e
merck
india
ltd
two
solvent
system
use
benzen
aceton
toluen
ethyl
acet
formic
acid
melt
point
determin
open
glass
capillari
use
kjeldahl
flask
contain
paraffin
uncorrect
h
nmr
c
nmr
spectra
taken
bruker
ultra
mhz
nmr
spectromet
dmsod
cdcl
use
tetramethylsilan
ch
si
intern
standard
chemic
shift
express
ppm
fourier
transform
infrar
ftir
spectra
record
kbr
pellet
jasco
ftir
spectromet
element
analys
realiz
perkineelm
model
analyz
within
theoret
valu
gener
procedur
synthesi
titl
compound
compound
g
mol
ad
mixtur
g
ml
mol
conc
nitric
acid
g
ml
mol
conc
sulfur
acid
frequent
shake
round
bottom
flask
keep
mixtur
cool
immers
flask
ice
cold
water
ad
flask
fit
reflux
condens
mixtur
heat
water
bath
maintain
temperatur
c
h
obtain
desir
compound
content
pour
beaker
contain
ml
cold
water
stir
order
wash
much
acid
desir
compound
compound
complet
settl
bottom
upper
acid
liquor
complet
pour
mixtur
residu
liquid
transfer
separ
funnel
shake
vigor
ml
water
bottom
layer
collect
dri
anhydr
calcium
chlorid
final
filter
obtain
pure
compound
b
compound
b
mol
iron
powder
mol
place
round
bottom
flask
contain
ml
ethanol
mixtur
heat
oil
bath
till
temperatur
attain
c
ml
hcl
ad
content
stir
h
maintain
temperatur
content
filter
reduc
pressur
filtrat
adjust
ph
use
nahco
get
precipit
compound
b
recrystal
ethanol
b
compound
b
mol
dissolv
ml
glacial
acet
acid
dilut
ml
conic
flask
solut
naocn
mol
ml
warm
water
ad
continu
shake
content
allow
stand
min
cool
ice
allow
stand
min
filter
pump
wash
water
dri
c
desir
compound
b
form
recrystal
ethanol
observ
next
min
presenc
absenc
seizur
episod
clonic
spasm
approxim
fort
andor
hindlimb
jaw
vibrissa
taken
endpoint
anim
meet
criterion
consid
protect
minim
clonic
seizur
hz
test
clinic
use
a
ineffect
standard
me
scptz
test
still
anticonvuls
activ
vivo
order
identifi
potenti
a
profil
compound
test
minim
clonic
seizur
hz
psychomotor
test
like
maxim
electroshock
me
test
minim
clonic
seizur
hz
test
use
assess
compound
efficaci
electr
induc
seizur
use
lower
frequenc
hz
longer
durat
stimul
test
compound
preadminist
mice
via
ip
inject
vari
time
individu
mice
four
mice
per
time
point
challeng
suffici
current
deliv
corneal
electrod
elicit
psychomotor
seizur
anim
untreat
mice
would
display
seizur
character
minim
clonic
phase
follow
stereotyp
automatist
behavior
describ
origin
similar
aura
human
patient
partial
seizur
anim
display
behavior
consid
protect
mice
rotorod
procedur
use
disclos
minim
muscular
neurolog
impair
mous
place
rod
rotat
speed
rpm
anim
maintain
equilibrium
long
period
time
anim
consid
toxic
fall
rotat
rod
three
time
period
rat
minim
motor
deficit
indic
ataxia
manifest
abnorm
uncoordin
gait
rat
use
evalu
toxic
examin
test
drug
administ
sinc
individu
anim
may
peculiar
gait
equilibrium
place
respons
etc
might
attribut
erron
test
substanc
partit
coeffici
octanol
phosphat
buffer
determin
room
temperatur
c
use
procedur
describ
elsewher
ten
millilit
octanol
ml
phosphat
buffer
ph
taken
glass
stopper
graduat
tube
mg
accur
weigh
drug
ad
mixtur
shaken
help
mechan
shaker
h
room
temperatur
mixtur
transfer
separ
funnel
allow
equilibr
h
aqueou
octanol
phase
separ
filter
membran
filter
drug
content
aqueou
phase
analyz
uv
spectroscopi
partit
coeffici
calcul
pc
ct
ca
ca
pc
partit
coeffici
ct
concentr
total
drug
ca
concentr
drug
aqueou
phase
